Cipla
CIPLA SWING TRADE 1 HOURHello TradingView community and my followers, please if you like the ideas, don't forget to support them with likes and comments, thank you very much and here we go.
.
CIPLA
Daily : Major daily trend is up.
1 hour : 1 hour trend is down but stock is showing chances of reversal. Stock is consolidating and taking multiple times liquidity from below and giving signal of going up.
*Wait & look for an opportunity and we could see an upside movement.
THANK YOU !!!!
#DIVISLAB #TORNTPHARM #ALKEM #AUROPHARMA #BIOCON #LUPIN #CIPLA #DIVISLAB
NSE: DIVISLAB
CMP: 3498
TP: 4200
SL: 3300
TF: <6m
RR > ~3.4 times
Return > 20%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#ASTERDM #BAJAJHCARE #MAXHEALTH #LAURUSLABS #NATCOPHARMA #GLAND #ASTERDM
NSE: ASTERDM
CMP: 225
TP: 300
SL: 200
TF: <6m
RR > ~3 times
Return > 33%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#BIOCON #LUPIN #DIVISLAB #ALKEM #IPCALAB #GRANULES #AUROPHARMA#BIOCON
NSE: BIOCON
CMP: 267
TP: 320
SL: 250
TF: <6m
RR > 4 times
Return > 20%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#AUROPHARMA #CIPLA #DIVISLAB #DRREDDY #LUPIN #GLENMARK #PFIZER #AUROPHARMA
NSE: AUROPHARMA
CMP: 437
TP: 535
SL: 400
TF: <6m
RR > 3.5 times
Return > 22%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#CIPLA #BALPHARMA #GLENMARK #SANOFI #PFIZER #AUROPHARMA #NIFTY50#CIPLA
NSE: CIPLA
CMP: 1128
TP: 1250
SL: 1080
TF: <6m
RR > 2.5 times
Return > 11%
THYROCARE CNXPHARMA LUPIN NSE: CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#THYROCARE #CNXPHARMA #LUPIN #CIPLA #SUNPHARMA #SPARC #DIVISLAB #THYROCARE
NSE: THYROCARE
CMP: 700
TP: 920
SL: 600
TF: <6m
RR > 2.3 times
Return > 30%
THYROCARE CNXPHARMA LUPIN CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
Cipla 1HRCipla is looking good setup for tomorrow trade Cipla formed head and shoulder pattern
in 1 day timeframe price in a crucial level if a candle break and close below the support
we can sell cipla first target will be 1078.50 and second will be 1066.20and trail your
stoploss if cipla braking upper green zone then we can avoid this trade
Thank you
NSE:CIPLA
Cipla Buying Opportunity1) The US recession talks are rising day by day. The recession is to come, we just don't know when, but it will come.
2) Inflation is at an all-time high. The IT sector is tanking like anything.
3) The Pharma sector is known to be recession-proof and inflation-proof. People will never stop spending on medicine and healthcare, no matter how expensive it gets.
4) Cipla is consolidating at its previous swing high.
5) The pharma sector has already corrected 1/3 after the 2020 rally.
6) almost all the sectors have recovered except for IT and PHarma. I believe if pharma rallies, then CIPLA will be the one leading the rally.